
The two HIV prevention drugs available in the United States are equally safe and effective, and the biggest difference between them is price, a new study contends. However, a sizable minority of patients have switched from the older and cheaper “preexposure prophylaxis” (PrEP) formulation to the newer and much pricier one. In many cases that… read on > read on >